Rigel Pharmaceuticals (RIGL) Gross Margin (2018 - 2026)
Rigel Pharmaceuticals' Gross Margin was 89.17% in Q2 2026, down 6.40 percentage points from 95.57% a year earlier and down 3.00 percentage points from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Gross Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rigel Pharmaceuticals' Gross Margin was 91.39% through Jun 30, 2026, down 0.13 percentage points year-over-year; for FY2025, it was 93.33%, up 3.73 percentage points from FY2024.
- Gross Margin shows a five-year change of -5.84 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 89.60% in FY2024 (-4.32 pp), 93.92% in FY2023 (-4.63 pp), 98.55% in FY2022 (-0.73 pp) and 99.27% in FY2021 (+0.10 pp).
- The Q2 2026 figure marks the lowest quarterly Gross Margin since Q3 2024.
- Compared with a year earlier, Gross Margin was higher in five of the last eight quarters, with an average year-over-year change of -0.56 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q3 2025 (a gain of 7.67 percentage points); the worst was Q3 2024 (a drop of 10.00 percentage points).
- Per Business Quant data, RIGL's Gross Margin in the three quarters before Q2 2026 was 92.17% (Q1 2026), 91.47% (Q4 2025) and 93.16% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 75.71% |
| 10 | Rigel Pharmaceuticals | 826.82 Mn | 330.55 Mn | 70.11 Mn | 86.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 86.67% |
| Jun 30, 2026 | 89.17% |
| Mar 31, 2026 | 92.17% |
| Dec 31, 2025 | 91.47% |
| Sep 30, 2025 | 93.16% |
| Jun 30, 2025 | 95.57% |
| Mar 31, 2025 | 91.73% |
| Dec 31, 2024 | 89.95% |
| Sep 30, 2024 | 85.49% |
| Jun 30, 2024 | 92.38% |
| Mar 31, 2024 | 93.14% |
| Dec 31, 2023 | 89.41% |
| Sep 30, 2023 | 95.49% |
| Jun 30, 2023 | 96.00% |
| Mar 31, 2023 | 96.25% |
| Dec 31, 2022 | 99.33% |
| Sep 30, 2022 | 98.88% |
| Jun 30, 2022 | 96.53% |
| Mar 31, 2022 | 99.28% |
| Dec 31, 2021 | 97.61% |
API Access
Rigel Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();